Drugs & medicalClass II

Fagron Compounding Services recalls Vancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS…

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Read the official notice →
Date
2026-04-15
Country
United States
Brand
Fagron Compounding Services
Product
Vancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS…
Classification
Class II
Units
Nationwide in the U.S.A.
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Fagron Compounding Services recalls

  1. 2025-12-17
  2. US
  3. 2025-09-24
  4. US
  5. 2025-02-26
  6. US
  7. 2024-08-28
  8. US
  9. 2023-12-06
  10. US
    Drugs & medicalClass III

    Fagron Compounding Services recalls Tropicamide 1% (10mg/mL), Cyclopentolate 1% (10mg/mL), Phenylephrine 2.5% (25mg/mL), Ketorolac 0.5% (5mg/mL), 5 mL bottles, For…

    Labeling: Label Mix-Up: The label of a dropper bottle mistakenly states the container is a 0.5mL single-use syringe instead of a 5 mL dropper

    FDA · DrugFagron Compounding ServicesNationwide in the USAOfficial notice →
All 6 Fagron Compounding Services recalls →

Other drugs & medical recalls in the United States

  1. 2026-04-15
  2. US
  3. US
  4. US
    Drugs & medicalClass II

    Preferred Pharmaceuticals, Inc. recalls Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 oz bottles, Mfg:…

    Lack of Assurance of Sterility

    FDA · DrugPreferred Pharmaceuticals, Inc.Nationwide within the United StatesOfficial notice →
  5. US
    Drugs & medicalClass II

    Fresenius Kabi USA, LLC recalls 0.9% Sodium Chloride Injection, USP, (2,250 mg per 250 mL) (9 mg per mL) 250 mL in a 250 mL freeflex bag, Rx only, Fresenius Kabi USA,…

    Lack of Assurance of Sterility

    FDA · DrugFresenius Kabi USA, LLCUS Nationwide , Alaska, and Puerto Rico.Official notice →
  6. US
    Drugs & medicalClass II

    Cipla USA, Inc. recalls Lanreotide Injection, 120 mg/0.5 mL, Box contains 1 Pre-filled syringe, Single dose only, Rx Only, Manufactured by: Pharmathen…

    Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.

    FDA · DrugCipla USA, Inc.Nationwide in the USAOfficial notice →
  7. 2026-04-08
  8. US
    Drugs & medicalClass II

    Cardinal Health 200, LLC recalls Cardinal Health Monoject Tuberculin Syringe, 1 mL Luer Lock, Catalog Number 1180100777

    The outer packaging and blister pack labeling identify the product as 1mL Luer Lock Tuberculin Syringe (Product Code 1180100777), however the syringes contained within the packages are U-100 Insulin syringes.

    FDA · DeviceCardinal Health 200, LLCWorldwide distribution - US Nationwide and the country of Canada.Official notice →
See all drugs & medical recalls →